Medicare Enrolled

Dr. Mitchell Latter, MD

Ophthalmology · South Pasadena, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1499 HUNTINGTON DR STE 508, South Pasadena, CA 91030
6267999588
In practice since 2006 (19 years)
NPI: 1255411625 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Latter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Latter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Latter

Dr. Mitchell Latter is an ophthalmology specialist in South Pasadena, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Latter performed 6,437 Medicare services across 3,894 unique beneficiaries.

Between the years covered by Open Payments, Dr. Latter received a total of $7,331 from 23 pharmaceutical and/or device companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Latter is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 15% volume in CA $7,331 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,437
Medicare services
Top 15% in CA for ophthalmology
3,894
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~339 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Microfluid analysis of tears
A laboratory test that analyzes tear fluid using microfluidic technology to measure specific biomarkers. This procedure helps evaluate the composition of tears for diagnostic purposes.
1,925 $22 $35
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
1,235 $68 $122
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
470 $21 $81
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
385 $96 $230
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
368 $28 $90
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
350 $31 $90
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
311 $47 $151
Extended color vision testing
A comprehensive eye exam that includes specialized tests to evaluate color vision.
302 $48 $70
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
278 $29 $100
Immunoassay substance analysis, multiple step method
A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material.
188 $11 $25
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
175 $40 $500
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
99 $90 $230
Ultrasound scan to determine eye length and lens power
An ultrasound procedure used to measure the length of the eye and calculate the power of the lens.
67 $49 $500
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
59 $462 $3,000
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
47 $9 $130
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
40 $29 $200
Amniotic membrane placement on eye surface
This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing.
27 $1,151 $2,500
Laser repair to improve eye fluid flow
A laser procedure used to enhance the drainage of fluid within the eye.
24 $195 $1,700
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
24 $15 $130
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
20 $69 $128
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
19 $277 $900
Eye photography
Photographic imaging of the interior structures of the eye.
13 $20 $85
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
11 $107 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
16.3% medium
82.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,331
Total received (2018-2024)
Avg $1,047/year across 7 years
Top 19% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
257
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,331 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,665
2023
$781
2022
$1,078
2021
$728
2020
$506
2019
$997
2018
$575

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
BIOTISSUE HOLDINGS INC.
$2,000
Bausch & Lomb Americas Inc.
$344
Oyster Point Pharma, Inc.
$180
Dompe US, Inc.
$103
Thea Pharma Inc.
$25
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Top 3 companies account for 94.7% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTISSUE HOLDINGS INC.
$2,000
Sun Pharmaceutical Industries Inc.
$1,445
TissueTech, Inc.
$749
Novartis Pharmaceuticals Corporation
$716
Bausch & Lomb, a division of Bausch Health US, LLC
$434
Allergan, Inc.
$403
Bausch & Lomb Americas Inc.
$367
SUN PHARMACEUTICAL INDUSTRIES INC.
$240
Oyster Point Pharma, Inc.
$180
TOPCON MEDICAL SYSTEMS, INC.
$125
Dompe US, Inc.
$121
Johnson & Johnson Surgical Vision, Inc.
$114
Eyevance Pharmaceuticals LLC
$66
Thea Pharma Inc.
$64
ABBVIE INC.
$59
Shire North American Group Inc
$51
EYEVANCE PHARMACEUTICALS LLC
$39
Carl Zeiss Meditec AG
$39
BIOTISSUE HOLDINGS, INC.
$28
Alcon Vision LLC
$25
TISSUETECH, INC.
$25
Allergan Inc.
$23
Beaver-Visitec International, Inc.
$18
Top 3 companies account for 57.2% of all-time payments
Associated products mentioned in payments ›
BESIVANCE · BROMSITE · BromSite · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · Cequa · DURYSTA · Flarex · IYUZEH · LOTEMAX SM · MIEBO · None Specified · OCT TRITON · OXERVATE · PROKERA · PROLENSA · Prokera · RESTASIS · RESTASIS MULTIDOSE · Rocklatan · TYRVAYA · Tecnis 1-piece IOL · TobraDex ST · Tobradex ST · VUITY · VYZULTA · XELPROS · XIIDRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in South Pasadena?
Compare ophthalmologists in the South Pasadena area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
781
Per 100K population
7.9
County median income
$87,760
Nearest hospital
ALHAMBRA HOSPITAL MEDICAL CENTER
2.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Latter is a mixed practice specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Latter experienced with microfluid analysis of tears?
Based on Medicare claims data, Dr. Latter performed 1,925 microfluid analysis of tears services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Latter receive payments from pharmaceutical companies?
Yes. Dr. Latter received a total of $7,331 from 23 companies across 257 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Latter's costs compare to other ophthalmologists in South Pasadena?
Dr. Latter's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Latter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →